Compare BCIC & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCIC | CPIX |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.6M | 98.3M |
| IPO Year | 2006 | 2007 |
| Metric | BCIC | CPIX |
|---|---|---|
| Price | $5.97 | $8.04 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $9.83 | N/A |
| AVG Volume (30 Days) | 32.3K | ★ 43.1K |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | ★ 17.68% | N/A |
| EPS Growth | ★ 262.50 | 58.70 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $42,010,949.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.75 |
| 52 Week Low | $6.33 | $1.85 |
| 52 Week High | $13.50 | $9.28 |
| Indicator | BCIC | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 19.05 | 59.09 |
| Support Level | N/A | $5.55 |
| Resistance Level | $7.57 | $8.30 |
| Average True Range (ATR) | 0.18 | 0.62 |
| MACD | -0.07 | 0.06 |
| Stochastic Oscillator | 0.87 | 70.40 |
BCP Investment Corp is an externally managed, non-diversified closed-end investment company. The company invests in secured term loans, bonds or notes and mezzanine debt in privately-held middle market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt and selected equity investments in privately-held middle market companies.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.